Bulletin
Investor Alert

Atea Pharmaceuticals Inc.

NAS: AVIR

GO
/marketstate/country/us

After Hours

/zigman2/quotes/222210381/composite

$

4.73

Change

+0.22 +4.88%

Volume

Volume 15,154

Feb 3, 2023, 6:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/222210381/composite

Today's close

$ 4.74

$ 4.51

Change

-0.23 -4.85%

Day low

Day high

$4.50

$4.79

Open
Open: 4.68

52 week low

52 week high

$4.18

$9.79

Open

Market cap

$394.78M

Average volume

431,523

P/E ratio

12.33

Rev. per Employee

$3.26M

EPS

0.37

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/avir

MarketWatch News on AVIR

  1. 8 Biotechs So Cheap Their Technology Is Effectively Free

    5:34 p.m. Feb. 16, 2022

    - Barron's Online

  2. Here Are 8 Biotech Stocks That Trade for Less Than Their Cash

    8:28 a.m. Dec. 28, 2021

    - Barron's Online

  3. Pfizer's Covid Antiviral Shows Stunning Efficacy

    10:46 p.m. Nov. 5, 2021

    - Barron's Online

  4. Atea Pharmaceuticals stock price target cut to $16 from $61 at J.P. Morgan

    6:56 a.m. Oct. 20, 2021

    - Tomi Kilgore

  5. Atea Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan

    6:55 a.m. Oct. 20, 2021

    - Tomi Kilgore

  6. Why Facebook May Be Changing Its Name

    10:42 a.m. Oct. 20, 2021

    - Barron's Online

  7. Stocks Closed Up Today. Profits Are a Beautiful Thing.

    4:30 p.m. Oct. 19, 2021

    - Barron's Online

  8. Don't Count Out Covid-19 Monoclonal Antibody Treatments

    10:33 a.m. Oct. 15, 2021

    - Barron's Online

  9. FDA Will Consider Regeneron's Covid-19 Antibody for Full Approval

    9:39 a.m. Oct. 14, 2021

    - Barron's Online

  10. Merck Submits Covid Pill to FDA for Emergency Approval

    9:11 a.m. Oct. 11, 2021

    - Barron's Online

  11. Dice Therapeutics and Hemisphere Media See Activist Action

    8:30 p.m. Oct. 1, 2021

    - Barron's Online

  12. Merck Says Pill Cuts Covid Hospitalization by 50%

    3:41 p.m. Oct. 1, 2021

    - Barron's Online

  13. Merck: Covid-19 Pill Looks Good Against Variants

    3:36 p.m. Sept. 29, 2021

    - Barron's Online

  14. Loading more headlines...
/news/nonmarketwatch/company/us/avir

Other News on AVIR

  1. 10-Q: ATEA PHARMACEUTICALS, INC.

    5:05 p.m. Nov. 7, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Horizon's (HZNP) Q3 Earnings & Revenues Surpass Estimates

    10:07 a.m. Nov. 3, 2022

    - Zacks.com

  3. Alkermes (ALKS) Q3 Earnings Meet Estimates, Revenues Miss

    10:43 a.m. Nov. 2, 2022

    - Zacks.com

  4. Incyte's (INCY) Q3 Earnings and Revenues Miss Estimates

    9:41 a.m. Nov. 1, 2022

    - Zacks.com

  5. Atea (AVIR) Dengue Candidate Gets Fast Track Designation

    8:53 a.m. Sept. 27, 2022

    - Zacks.com

  6. Atea wins FDA Fast Track status for dengue treatment

    6:44 a.m. Sept. 26, 2022

    - Seeking Alpha

  7. AJU IB Investment Co., Ltd. Buys 3, Sells 2 in 2nd Quarter

    8:00 a.m. Aug. 9, 2022

    - GuruFocus.com

  8. Loading more headlines...
/news/pressrelease/company/us/avir

Press Releases on AVIR

  1. Atea Pharmaceuticals Highlights Strategic Priorities for 2023

    7:00 a.m. Jan. 9, 2023

    - GlobeNewswire

  2. Atea Pharmaceuticals Announces Upcoming Investor Events

    6:00 a.m. Sept. 7, 2022

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.